Medtronic logo updatedMedtronic (NYSE:MDT) today announced that it has initiated a Define AFib app-based research study.

The Dublin, Ireland-based company will conduct the atrial fibrillation (AFib) study remotely using data collected from its Linq family of insertable cardiac monitors (ICM) on its Medtronic Discovery App to address questions around AFib burden and its impact on patient outcomes, quality of life and healthcare utilization.

Get the full story on our sister site, Medical Design & Outsourcing.